ERIN SHAW: Open Payments
NPI 1609378454 · PORT NECHES, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 38 payments from 10 companies in 2025. Trend: 2023 $548 · 2024 $570 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $234 |
| Novo Nordisk Inc | 4 | $77 |
| Kowa Pharmaceuticals America, Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $36 |
| PFIZER INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: UBRELVY, QULIPTA, VRAYLAR, ZORYVE, Auvelity, INSPIRE, Wegovy, Rybelsus.
Industry payments across TX — which companies pay providers there.
